Sep/Oct 2003 - After the Women's Health Initiative Trial

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Sep/Oct 2003 - After the Women's Health Initiative Trial

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2003 Pg. 324-328	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
Sep/Oct 2003 Pg. 330-338	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Author(s): Gillson George R, Zava David T
Sep/Oct 2003 Pg. 339	Patient Handout - Hormone Replacement Therapy Author(s): Reed-Kane Dana
Sep/Oct 2003 Pg. 341-344	The Role of the Pharmacist in Diabetes Care Author(s): Meece Jerry
Sep/Oct 2003 Pg. 345-347	Understanding Feline Hyperthyroidism Author(s): Davidson Gigi S
Sep/Oct 2003 Pg. 350-352	Profile of a Practice: Don West, RPh, Lloyd Center Pharmacy, Portland, Oregon Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 354-356	Sterile Vancomycin Pluronic Gel for Implantation in the Chest-Wall Cavity to Treat Resistant Pneumococcus Author(s): Gray Cary, Shome Sibaji, Muller George
Sep/Oct 2003 Pg. 354	Vancomycin Pluronic Gel Author(s): Gray Cary, Shome Sibaji, Muller George
Sep/Oct 2003 Pg. 358-359	NDC Numbers: A New Approach Author(s): Heckman H Edward
Sep/Oct 2003 Pg. 361-363 View Sample	Application of USP-NF Standards to Pharmacy Compounding Author(s): Bormel Gail, Valentine Joseph G, Williams Roger L
Sep/Oct 2003 Pg. 364-365	Technology Spotlight: Respiratory Vial Sealers Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 366-369	Basics of Compounding for Pediculosis Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 368	Malathion 0.5% Topical Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 368	Ivermectin 1% Crème Rinse Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 369	Ivermectin 1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 369	Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 370-371	Standard Operating Procedure: Incubator Cleaning Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 372	Calculations Author(s): Prince Shelly J
Sep/Oct 2003 Pg. 373	Chloramphenicol 1% Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 374	Guanethidine Monosulfate 10-mg and Hydrochlorothiazide 25-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 375	Indomethacin 50-mg Suppositories Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 376	Isoniazid 10-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 377	Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 378	Perphenazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 379	Phenylbutazone 100-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 380	Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 381	Thioridazine HCl 100-mg/mL Concentrated Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 382	Ursodiol 150-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 383-385	Quality-Control Analytical Methods: Refractometry Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 386-388	Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Author(s): Gupta Vishnu D
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2003 Pg. 394-398	Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Author(s): McElhiney Linda F
Sep/Oct 2003 Pg. 400	Postcriptions: Compounding Paradox: Taught Less and Practiced More Author(s): Newton David W
Sep/Oct 2003 Pg. 401-416	An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices Author(s): Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D